Insider Trading disclosures for Galera Therapeutics Inc

The latest disclosure was made by J. Mel Sorensen in Galera Therapeutics Inc where a trade of 6,000,000 Stock Option (Right to Buy) done was reported to US exchanges on May 1, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
J. Mel Sorensen	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2025	6,000,000	6,000,000	-		-	Stock Option (Right to Buy)
Joel Sussman	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2025	2,000,000	2,000,000	-		-	Stock Option (Right to Buy)
G. Kevin Lokay	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Feb 2025	48,000	48,000	-		-	Stock Option (Right to Buy)
Alleva Lawrence M.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Feb 2025	48,000	48,000	-		-	Stock Option (Right to Buy)
J. Mel Sorensen	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 0.07 per share.	16 Aug 2024	67,015	265,029 (1%)	0%	0.1	4,825	Common Stock
Lawrence M. Alleva	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2023	22,762	22,762	-		-	Stock Option (Right to Buy)
Linda West	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2023	23,382	23,382	-		-	Stock Option (Right to Buy)
Kevin G. Lokay	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	48,000	48,000	-		-	Stock Option (Right to Buy)
Michael F. Powell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	64,000	64,000	-		-	Stock Option (Right to Buy)
Lawrence M. Alleva	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	48,000	48,000	-		-	Stock Option (Right to Buy)
Emmett Cunningham	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	48,000	0	-		-	Stock Option (Right to Buy)
Linda West	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2023	48,000	48,000	-		-	Stock Option (Right to Buy)
Mark Bachleda	Chief Commercial Officer	Purchase of securities on an exchange or from another person at price $ 2.25 per share.	16 Mar 2023	11,000	11,000 (0%)	0%	2.2	24,717	Common Stock
Christopher Degnan	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 1.96 per share.	13 Mar 2023	10,000	10,000 (0%)	0%	2.0	19,593	Common Stock
J. Mel Sorensen	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 1.68 per share.	10 Mar 2023	100,000	332,044 (1%)	0%	1.7	168,120	Common Stock
Jennifer Evans Stacey	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2023	135,000	135,000	-		-	Stock Option (Right to Buy)
J. Mel Sorensen	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2023	440,000	440,000	-		-	Stock Option (Right to Buy)
Eugene P. Kennedy	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2023	55,000	55,000	-		-	Stock Option (Right to Buy)
Christopher Degnan	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2023	185,000	185,000	-		-	Stock Option (Right to Buy)
Robert A. Beardsley	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2023	135,000	135,000	-		-	Stock Option (Right to Buy)
Mark Bachleda	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2023	135,000	135,000	-		-	Stock Option (Right to Buy)
Robert A. Beardsley	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Nov 2022	10,000	75,651	-		-	Stock Option
Robert A. Beardsley	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	21 Nov 2022	10,000	108,191 (0%)	0%	1.1	10,700	Common Stock
Robert A. Beardsley	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2022	10,000	85,651	-		-	Stock Option
Robert A. Beardsley	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	12 Sep 2022	10,000	98,191 (0%)	0%	1.1	10,700	Common Stock
Lawrence M. Alleva	Director	Gift of securities by or to the insider at price $ 0.00 per share.	18 Jul 2022	4,000	2,325 (0%)	0%		0	Common Stock
Linda West	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2022	58,496	58,496	-		-	Stock Option (Right to Buy)
Kevin G. Lokay	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	15,000	15,000	-		-	Stock Option (Right to Buy)
Michael F. Powell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	20,000	20,000	-		-	Stock Option (Right to Buy)
Lawrence M. Alleva	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	15,000	15,000	-		-	Stock Option (Right to Buy)
Emmett Cunningham	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	15,000	0	-		-	Stock Option (Right to Buy)
Linda West	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	15,000	15,000	-		-	Stock Option (Right to Buy)
Jennifer Evans Stacey	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Feb 2022	75,000	75,000	-		-	Stock Option (Right to Buy)
Jon T. Holmlund	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Feb 2022	75,000	75,000	-		-	Stock Option (Right to Buy)
J. Mel Sorensen	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Feb 2022	264,400	264,400	-		-	Stock Option (Right to Buy)
Christopher Degnan	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Feb 2022	135,000	135,000	-		-	Stock Option (Right to Buy)
Robert A. Beardsley	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Feb 2022	75,000	75,000	-		-	Stock Option (Right to Buy)
Mark Bachleda	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Feb 2022	75,000	75,000	-		-	Stock Option (Right to Buy)
Robert A. Beardsley	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Dec 2021	20,000	95,651	-		-	Stock Option
Robert A. Beardsley	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	17 Dec 2021	20,000	88,191 (0%)	0%	1.1	21,400	Common Stock
Linda West	Director	Purchase of securities on an exchange or from another person at price $ 2.74 per share.	17 Dec 2021	20,000	60,000 (0%)	0%	2.7	54,804	Common Stock
Mark Bachleda	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Oct 2021	200,000	200,000	-		-	Stock Option (Right to Buy)
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.43 per share.	01 Sep 2021	47,756	47,756 (0%)	0%	2.4	116,047	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Sep 2021	47,756	61,142	-		-	Stock Option
Jon T. Holmlund	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 8.47 per share.	01 Sep 2021	47,756	0 (0%)	0%	8.5	404,498	Common Stock
Lawrence M. Alleva	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2021	8,498	8,498	-		-	Stock Option (Right to Buy)
Emmett Cunningham	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2021	5,408	0	-		-	Stock Option (Right to Buy)
Linda West	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2021	8,730	8,730	-		-	Stock Option (Right to Buy)
Kevin G. Lokay	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	9,888	9,888	-		-	Stock Option (Right to Buy)
Michael F. Powell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	13,179	13,179	-		-	Stock Option (Right to Buy)
Lawrence M. Alleva	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	9,888	9,888	-		-	Stock Option (Right to Buy)
Emmett Cunningham	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	9,888	0	-		-	Stock Option (Right to Buy)
Linda West	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2021	9,888	9,888	-		-	Stock Option (Right to Buy)
Linda West	Director	Purchase of securities on an exchange or from another person at price $ 9.13 per share.	15 Jun 2021	10,000	40,000 (0%)	0%	9.1	91,300	Common Stock
Lawrence M. Alleva	Director	Purchase of securities on an exchange or from another person at price $ 8.59 per share.	01 Jun 2021	4,045	4,045 (0%)	0%	8.6	34,741	Common Stock
Linda West	Director	Purchase of securities on an exchange or from another person at price $ 8.64 per share.	28 May 2021	10,000	20,000 (0%)	0%	8.6	86,381	Common Stock
Linda West	Director	Purchase of securities on an exchange or from another person at price $ 8.64 per share.	28 May 2021	10,000	10,000 (0%)	0%	8.6	86,410	Common Stock
J. Mel Sorensen	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.14 per share.	26 Mar 2021	46,940	232,044 (0%)	0%	1.1	53,512	Common Stock
J. Mel Sorensen	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Mar 2021	46,940	0	-		-	Stock Option (Right to Buy)
J. Mel Sorensen	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Mar 2021	170,075	0	-		-	Stock Option (Right to Buy)
J. Mel Sorensen	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	26 Mar 2021	170,075	185,104 (0%)	0%	1.1	181,980	Common Stock
Jon T. Holmlund	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2021	71,250	71,250	-		-	Stock Option (Right to Buy)
J. Mel Sorensen	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2021	190,000	190,000	-		-	Stock Option (Right to Buy)
Arthur J. Fratamico	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2021	75,000	75,000	-		-	Stock Option (Right to Buy)
Christopher Degnan	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2021	82,500	82,500	-		-	Stock Option (Right to Buy)
Robert A. Beardsley	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2021	75,000	75,000	-		-	Stock Option (Right to Buy)
Joel Sussman	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2021	50,000	50,000	-		-	Stock Option (Right to Buy)
Lawrence M. Alleva	Director	Purchase of securities on an exchange or from another person at price $ 10.22 per share.	13 Nov 2020	2,325	6,325 (0%)	0%	10.2	23,771	Common Stock
Joel Sussman	Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Nov 2020	2,639	32,238	-		-	Stock Option (Right to Buy)
Joel Sussman	Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Nov 2020	3,755	0	-		-	Stock Option (Right to Buy)
Joel Sussman	Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Nov 2020	3,606	0	-		-	Stock Option (Right to Buy)
Joel Sussman	Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Nov 2020	10,000	3,606	-		-	Stock Option (Right to Buy)
Joel Sussman	Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 10.32 per share.	12 Nov 2020	10,000	0 (0%)	0%	10.3	103,197	Common Stock
Joel Sussman	Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.43 per share.	12 Nov 2020	2,639	10,000 (0%)	0%	2.4	6,413	Common Stock
Joel Sussman	Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.14 per share.	12 Nov 2020	3,755	7,361 (0%)	0%	1.1	4,281	Common Stock
Joel Sussman	Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	12 Nov 2020	3,606	3,606 (0%)	0%	1.1	3,858	Common Stock
Joel Sussman	Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 10.06 per share.	12 Nov 2020	10,000	0 (0%)	0%	10.1	100,627	Common Stock
Joel Sussman	Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	12 Nov 2020	10,000	10,000 (0%)	0%	1.1	10,700	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.43 per share.	26 Oct 2020	2,244	2,244 (0%)	0%	2.4	5,453	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 Oct 2020	2,244	108,898	-		-	Stock Option
Jon T. Holmlund	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 15.00 per share.	26 Oct 2020	2,244	0 (0%)	0%	15	33,660	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	05 Oct 2020	100	100 (0%)	0%	1.1	107	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Oct 2020	5,632	0	-		-	Stock Option
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Oct 2020	4,904	0	-		-	Stock Option
Jon T. Holmlund	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 12.00 per share.	05 Oct 2020	100	0 (0%)	0%	12	1,200	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Oct 2020	100	4,904	-		-	Stock Option
Jon T. Holmlund	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 12.00 per share.	05 Oct 2020	10,536	0 (0%)	0%	12	126,432	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.14 per share.	05 Oct 2020	5,632	5,632 (0%)	0%	1.1	6,420	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	05 Oct 2020	4,904	4,904 (0%)	0%	1.1	5,247	Common Stock
Kevin G. Lokay	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2020	9,888	9,888	-		-	Stock Option (Right to Buy)
Michael F. Powell	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2020	13,179	13,179	-		-	Stock Option (Right to Buy)
Lawrence M. Alleva	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2020	9,888	9,888	-		-	Stock Option (Right to Buy)
Emmett Cunningham	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2020	9,888	0	-		-	Stock Option (Right to Buy)
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	26 May 2020	692	5,004	-		-	Stock Option
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	26 May 2020	692	692 (0%)	0%	1.1	740	Common Stock
Jon T. Holmlund	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 12.00 per share.	26 May 2020	692	0 (0%)	0%	12	8,304	Common Stock
Jon T. Holmlund	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 12.00 per share.	20 May 2020	1,174	0 (0%)	0%	12	14,088	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	20 May 2020	1,174	1,174 (0%)	0%	1.1	1,256	Common Stock
Jon T. Holmlund	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 12.00 per share.	20 May 2020	969	0 (0%)	0%	12	11,628	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	20 May 2020	969	969 (0%)	0%	1.1	1,037	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 May 2020	1,174	5,696	-		-	Stock Option
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 May 2020	969	6,870	-		-	Stock Option
Jon T. Holmlund	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 12.00 per share.	08 May 2020	185	0 (0%)	0%	12	2,220	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	08 May 2020	185	185 (0%)	0%	1.1	198	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	08 May 2020	5,102	5,102 (0%)	0%	1.1	5,459	Common Stock
Jon T. Holmlund	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 12.00 per share.	08 May 2020	5,102	0 (0%)	0%	12	61,224	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 May 2020	671	7,839	-		-	Stock Option
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 May 2020	185	8,510	-		-	Stock Option
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 May 2020	5,102	8,695	-		-	Stock Option
Jon T. Holmlund	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 12.00 per share.	08 May 2020	671	0 (0%)	0%	12	8,052	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	08 May 2020	671	671 (0%)	0%	1.1	718	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	05 May 2020	3,064	3,064 (0%)	0%	1.1	3,278	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 May 2020	2,059	13,797	-		-	Stock Option
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 May 2020	1,489	15,856	-		-	Stock Option
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 May 2020	3,064	17,345	-		-	Stock Option
Jon T. Holmlund	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 12.00 per share.	05 May 2020	2,059	0 (0%)	0%	12.0	24,709	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	05 May 2020	2,059	2,059 (0%)	0%	1.1	2,203	Common Stock
Jon T. Holmlund	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 12.00 per share.	05 May 2020	1,489	0 (0%)	0%	12	17,868	Common Stock
Jon T. Holmlund	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share.	05 May 2020	1,489	1,489 (0%)	0%	1.1	1,593	Common Stock
Jon T. Holmlund	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 12.16 per share.	05 May 2020	3,064	0 (0%)	0%	12.2	37,258	Common Stock
Linda West	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2020	19,776	19,776	-		-	Stock Option (Right to Buy)
Lawrence M. Alleva	None	Purchase of securities on an exchange or from another person at price $ 9.78 per share.	13 Dec 2019	4,000	4,000 (0%)	0%	9.8	39,139	Common Stock
Robert A. Beardsley	Chief Operating Officer		12 Nov 2019	15,361	68,191 (0%)	0%		0	Common Stock
Robert A. Beardsley	Chief Operating Officer		12 Nov 2019	68,907	0	-		-	Series A Preferred Stock
Robert A. Beardsley	Chief Operating Officer		12 Nov 2019	2,000	0	-		-	Series B Preferred Stock
Robert A. Beardsley	Chief Operating Officer		12 Nov 2019	6,774	0	-		-	Series C Preferred Stock
Michael F. Powell	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Nov 2019	19,776	19,776	-		-	Stock Option
Emmett Cunningham	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Nov 2019	19,776	0	-		-	Stock Options (Right to Buy)
Christopher Degnan	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Nov 2019	229,513	229,513	-		-	Stock Option
Jason Fuller	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Nov 2019	19,776	19,776	-		-	Stock Option

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

Insider Trading disclosures for Galera Therapeutics Inc

The latest disclosure was made by J. Mel Sorensen in Galera Therapeutics Inc where a trade of 6,000,000 Stock Option (Right to Buy) done was reported to US exchanges on May 1, 2025.

Screeners based on Insider Trading and SAST parameters